BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26455581)

  • 21. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement.
    Chae H; Lim J; Kim M; Park J; Kim Y; Han K; Lee S; Min WS
    Ann Hematol; 2012 Feb; 91(2):193-201. PubMed ID: 21720744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel translocation t(1;5)(p32;q31) that was not associated with the TAL1 rearrangement in a case of T lymphoblastic leukemia/lymphoma.
    Cho HS; Kim MK; Bae YK
    Korean J Lab Med; 2009 Jun; 29(3):199-203. PubMed ID: 19571616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
    Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
    Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion.
    Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. t(1:14) and trisomy 4 in a patient with concomitant leukaemias.
    Zahir MN; Masood N; Shabbir-Moosajee M
    J Pak Med Assoc; 2014 May; 64(5):596-8. PubMed ID: 25272555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and clinical relevance of BCR-ABL fusion gene in childhood T-lineage acute lymphoblastic leukemia: a report on 4 cases.
    Sazawal S; Bakhshi S; Raina V; Swaroop C; Saxena R
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):850-2. PubMed ID: 19816207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of T cell lymphoblastic lymphoma in children and adolescents: Israel Society of Pediatric Hematology Oncology retrospective study.
    Katz OB; Ben Barak A; Abrahami G; Arad N; Burstein Y; Dvir R; Fischer S; Kapelushnik J; Kaplinsky H; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Futerman B; Ben-Arush MW
    Isr Med Assoc J; 2011 Mar; 13(3):161-5. PubMed ID: 21608337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia.
    Milani G; Matthijssens F; Van Loocke W; Durinck K; Roels J; Peirs S; Thénoz M; Pieters T; Reunes L; Lintermans B; Vandamme N; Lammens T; Van Roy N; Van Nieuwerburgh F; Deforce D; Schwab C; Raimondi S; Dalla Pozza L; Carroll AJ; De Moerloose B; Benoit Y; Goossens S; Berx G; Harrison CJ; Basso G; Cavé H; Sutton R; Asnafi V; Meijerink J; Mullighan C; Loh M; Van Vlierberghe P
    Br J Haematol; 2019 Apr; 185(1):169-174. PubMed ID: 29938777
    [No Abstract]   [Full Text] [Related]  

  • 30. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.
    Speleman F; Cauwelier B; Dastugue N; Cools J; Verhasselt B; Poppe B; Van Roy N; Vandesompele J; Graux C; Uyttebroeck A; Boogaerts M; De Moerloose B; Benoit Y; Selleslag D; Billiet J; Robert A; Huguet F; Vandenberghe P; De Paepe A; Marynen P; Hagemeijer A
    Leukemia; 2005 Mar; 19(3):358-66. PubMed ID: 15674412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
    Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
    Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies.
    Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xing YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
    Int J Lab Hematol; 2011 Dec; 33(6):e25-7. PubMed ID: 21679311
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of the absence of biallelic deletion at the
    Farah N; Kirkwood AA; Rahman S; Leon T; Jenkinson S; Gale RE; Patrick K; Hancock J; Samarasinghe S; Linch DC; Moorman AV; Goulden N; Vora A; Mansour MR
    Haematologica; 2018 Jul; 103(7):e288-e292. PubMed ID: 29519867
    [No Abstract]   [Full Text] [Related]  

  • 37. Myeloid and lymphoid neoplasms with FGFR1 abnormalities: diagnostic and therapeutic challenges.
    Savage NM; Johnson RC; Gotlib J; George TI
    Am J Hematol; 2013 May; 88(5):427-30. PubMed ID: 22886804
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.
    La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C
    Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia.
    Wu L; Xu Y; Wang Q; Ruan C; Drexler HG; Wu D; MacLeod RA; Chen S
    Haematologica; 2015 Jun; 100(6):e233-6. PubMed ID: 25682596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.